CXCL10 and COVID-19: Severely ill COVID-19 patients display lung tissue damage associated with cell death and pathologic inflammation [1,2], which are linked to enhanced pro-inflammatory cytokine and chemokine levels (e.g., TNF-α and CXCL10) [3,4].